Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trans sodium crocetinate for reperfusion injury in STEMI undergoing primary PCI
IRCT20120520009801N5Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of trans sodium crocetinate and acetaminophen in myocardial infarction (MI) (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Troponin I. Started Sep 2021; status: completed.
02
Drugs
trans sodium crocetinateacetaminophen
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on IRCT20120520009801N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120520009801N5.